Vimarsana
Biggest News Aggregation in the World

Page 3 - Ideaforge Ipo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ideaforge Ipo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ideaforge Ipo Today - Breaking & Trending Today

Ideaforge IPO opens for subscription. Should you bid? - Vimarsana News

Ideaforge IPO opens for subscription. Should you bid?

Ideaforge, India's leading drone manufacturer, has opened its initial public offering (IPO) for subscription. The company has raised INR2.54bn ($34m) from anchor investors, including HSBC, Invesco, and Goldman Sachs. The IPO is priced between INR638-672 per share, with analysts arguing it is reasonably valued given the potential for future growth. With a 50% market share in India's unmanned aircraft systems (UAS) industry, the drones made by Ideaforge are suitable for mapping, security, and surveillance. The IPO consists of an issue of equity shares worth INR2.4bn and an offer for sale of 4.8 ...

IdeaForge IPO fully booked on day 1; should you bid? Read what analysts say - Vimarsana News

IdeaForge IPO fully booked on day 1; should you bid? Read what analysts say

According to IPO watch, shares of IdeaForge enjoyed a premium of Rs 450 in grey markets, implying a likely listing price of Rs 1,122 on the upper price band

ideaforge ipo: Taking Stock: IPO mart sees disappointing H1 as listing gains elude investors. What's in store ahead? - Vimarsana News

ideaforge ipo: Taking Stock: IPO mart sees disappointing H1 as listing gains elude investors. What's in store ahead?

The primary market in India has experienced a weak first half with only eight companies launching IPOs, leading to earnings of Rs 5,800 crore. This is an 85% YoY drop compared to the same period in 2018. Inflation uncertainty and high interest rates made investors wary in the opening months, but sentiment picked up towards the close of H1. Mankind Pharma raised Rs 4,300 crore in its IPO, which was the largest issue launched by a drug maker since Gland Pharma in 2017. Analysts predict the remainder of the year will fare better than H1.

Ideaforge IPO: Solid Start! Ideaforge IPO fully subscribed within hours of opening on robust retail demand - Vimarsana News

Ideaforge IPO: Solid Start! Ideaforge IPO fully subscribed within hours of opening on robust retail demand

The robust demand was driven by retail investors, whose category was subscribed 4.38 times. While the non-institutional portion was subscribed 1.03 times, there were no bids yet from qualified institutional buyers.

Ideaforge IPO: Ideaforge IPO: GMP soars nearly 80% as issue gets fully subscribed. Here's what brokerages say - Vimarsana News

Ideaforge IPO: Ideaforge IPO: GMP soars nearly 80% as issue gets fully subscribed. Here's what brokerages say

The NII part was subscribed 1.89 times so far, while there were no bids from qualified institutional buyers. According to market sources, the company's shares are commanding a premium of Rs 525-530 in the unlisted market, indicating big listing gains for investors if the trends sustain.